We are live on ! Find out more
MS

Maven Securities Portfolio holdings

AUM $5.2B
1-Year Est. Return 44.01%
This Fund
S&P 500
This Quarter Est. Return
+9.57%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
AUM
$2.48B
AUM Growth
+$249M
Cap. Flow
+$50.8M
Cap. Flow %
2.05%
Top 10 Hldgs %
26.01%
Holding
1,560
New
411
Increased
288
Reduced
223
Closed
552

Sector Composition

Rank Sector Weight
1 Healthcare 9.96%
2 Industrials 4.3%
3 Technology 4.06%
4 Financials 3.71%
5 Communication Services 2.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
226
CALL
Pfizer
PFE
$140B
$1.99M 0.08%
+50,800
New +$1.98M
DLR icon
227
PUT
Digital Realty Trust
DLR
$73.7B
$1.99M 0.08%
13,200
+8,300
+169% +$1.25M
XNTK icon
228
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.06B
$1.99M 0.08%
30,300
+1,900
+7% +$284K
NUE icon
229
PUT
Nucor
NUE
$56.4B
$1.98M 0.08%
20,600
-3,100
-13% -$290K
D icon
230
PUT
Dominion Energy
D
$62.5B
$1.97M 0.08%
26,800
+23,700
+765% +$1.83M
SLB icon
231
SLB Ltd
SLB
$77.8B
$1.97M 0.08%
61,489
+11,489
+23% +$353K
ARKK icon
232
PUT
ARK Innovation ETF
ARKK
$5.89B
$1.96M 0.08%
+15,000
New +$1.75M
AXSM icon
233
Axsome Therapeutics
AXSM
$12.4B
$1.94M 0.08%
+27,548
New +$1.65M
EW icon
234
PUT
Edwards Lifesciences
EW
$47.6B
$1.93M 0.08%
18,600
+14,200
+323% +$1.34M
CFIVU
235
DELISTED
CF Acquisition Corp. IV Unit
CFIVU
$1.92M 0.08%
192,023
JNJ icon
236
Johnson & Johnson
JNJ
$635B
$1.92M 0.08%
11,641
+9,372
+413% +$1.55M
V icon
237
Visa
V
$677B
$1.91M 0.08%
8,161
+426
+6% +$97.4K
NKE icon
238
PUT
Nike
NKE
$61.9B
$1.9M 0.08%
12,300
+7,000
+132% +$942K
PDSB icon
239
PDS Biotechnology
PDSB
$38.1M
$1.89M 0.08%
+161,305
New +$1.26M
KOD icon
240
Kodiak Sciences
KOD
$2.59B
$1.88M 0.08%
+20,347
New +$1.95M
NTRS icon
241
PUT
Northern Trust
NTRS
$22.2B
$1.87M 0.08%
16,200
+6,300
+64% +$722K
AVAH icon
242
Aveanna Healthcare
AVAH
$2.06B
$1.87M 0.08%
+150,000
New +$1.78M
DE icon
243
PUT
Deere & Co
DE
$170B
$1.87M 0.08%
5,300
+2,100
+66% +$767K
RMGCU
244
DELISTED
RMG Acquisition Corp. III Unit
RMGCU
$1.86M 0.08%
186,364
+86,364
+86% +$865K
CVAC
245
PUT
DELISTED
CureVac
CVAC
$1.86M 0.07%
+25,300
New +$2.53M
REGN icon
246
PUT
Regeneron Pharmaceuticals
REGN
$68.8B
$1.84M 0.07%
3,300
+2,100
+175% +$1.06M
VST icon
247
Vistra
VST
$55.1B
$1.84M 0.07%
+100,000
New +$1.73M
IDXX icon
248
PUT
Idexx Laboratories
IDXX
$42.9B
$1.83M 0.07%
2,900
+700
+32% +$387K
NOC icon
249
PUT
Northrop Grumman
NOC
$77B
$1.82M 0.07%
5,000
+3,600
+257% +$1.3M
LPRO
250
Open Lending Corp
LPRO
$373M
$1.81M 0.07%
42,847
-64,955
-60% -$2.5M

Similar funds

Maven Securities's Q2 2021 Portfolio in Review

As of Q2 2021, Maven Securities held 1,560 positions worth $2.48B, up 11% from $2.23B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Maven Securities's Q2 2021 filing shows 411 new, 288 increased, 223 reduced and 552 closed positions. Its largest new stake was Proofpoint, Inc.: 175,167 shares worth $30.4M. The largest sale was Invesco QQQ Trust, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 13% a quarter earlier, followed by Industrials and Technology.

  • Maven Securities's largest Q2 2021 buy was Proofpoint, Inc.: 175,167 shares worth $30.4M.
  • Maven Securities added most to Xilinx Inc in Q2 2021, an estimated $14.8M increase.
  • Maven Securities's biggest Q2 2021 reduction was Invesco QQQ Trust, cutting an estimated $46.1M.
  • Maven Securities fully exited RealPage, Inc. in Q2 2021, selling an estimated $26.3M.
  • Maven Securities's ten largest holdings make up 26% of its $2.48B portfolio in Q2 2021.
  • Maven Securities opened 411 new positions and closed 552 in Q2 2021.
  • Maven Securities's portfolio value rose 11% quarter-over-quarter to $2.48B.

Based on Maven Securities's 13F filing for Q2 2021, filed 16 Aug 2021.